Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress

International Journal of Urology

Volumn 17, Issue 12, 2010, Pages 989-995

  Hayashi, Taiji ^a   De Velasco, Marco Antonio ^a   Saitou, Yoshitaka ^a   Nose, Kazuhiro ^a   Nishioka, Tsukasa ^a   Ishii, Tokumi ^a   Uemura, Hirotsugu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carvedilol; Ischemia reperfusion injury; Oxidative stress; Renal failure

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CARVEDILOL; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; EPITHELIUM CELL; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SHAM PROCEDURE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; CARBAZOLES; CREATININE; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; KIDNEY TUBULES; MALE; OXIDATIVE STRESS; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 78649546659     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02644.x     Document Type: Article

References (21)

1. Hestin D, Johns EJ. The influence of allopurinol on kidney haemodynamic and excretory responses to renal ischaemia in anaesthetized rats. Br. J. Pharmacol. 1999; 128: 255-61.
2. Finn WF. Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ. Res. 1980; 46: 440-8.
3. Honda N, Hishida A. Pathophysiology of experimental nonoliguric acute renal failure. Kidney Int. 1993; 43: 513-21.
4. Stein JH, Lifschitz MD, Barnes LD. Current concepts on the pathophysiology of acute renal failure. Am. J. Physiol. 1978; 234: F171-F181.
5. Lameire N, Vanholder R. Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J. Am. Soc. Nephrol. 2001; 12: S20-S32.
6. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am. J. Med. 2000; 109: 665-78.
7. Weight S, Bell PR, Nicholson ML. Renal ischemia-reperfusion injury. Br. J. Surg. 1996; 83: 162-70.
8. Ho YS, Magnenat JL, Gargano M, Cao J. The nature of antioxidant defense mechanisms: a lesson from transgenic studies. Environ Health Perspect. 1998; 106 (Suppl 5): 1219-28.
9. Yin M, Wheeler MD, Connor HD et al. Cu/Zn-superoxide dismutase gene attenuates ischemia-reperfusion injury in the rat kidney. J. Am. Soc. Nephrol. 2001; 12: 2691-700.
10. Yue TL, Mckenna PJ, Lysko PG, Ruffolo RR Jr, Feuerstein GZ. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper. Atherosclerosis 1992; 97: 209-16.
11. Yue TL, Mckenna PJ, Gu JL, Cheng HY, Ruffolo RR Jr, Feuerstein GZ. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells. Hypertension 1993; 22: 922-8.
12. Singh D, Chander V, Chopra K. Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats. Fundam. Clin. Pharmacol. 2004; 18: 627-34.
13. Akbas H, Ozden M, Kanko M et al. Protective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injury. J. Int. Med. Res. 2005; 33: 528-36.
14. Hayashi T, Saitou Y, Nose K, Nishioka T, Ishii T, Uemura H. Efficacy of Carvedilol for ischemia/reperfusion-induced oxidative renal injury in rats. Transplant. Proc. 2008; 40: 2139-41.
15. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N. Engl. J. Med. 1996; 334: 1448-60.
16. Paller MS. The cell biology of reperfusion injury in the kidney. J. Investig. Med. 1994; 42: 632-9.
17. Eum HA, Lee SM. Effects of Trolox on the activity and gene expression of cytochrome P450 in hepatic ischemia/reperfusion. Br. J. Pharmacol. 2004; 142: 35-42.
18. Avunduk MC, Yurdakul T, Erdemli E, Yavuz A. Prevention of renal damage by alpha tocopherol in ischemia and reperfusion models of rats. Urol. Res. 2000; 31: 280-5.
19. Yue TL, Cheng HY, Lysko PG et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J. Pharmacol. Exp. Ther. 1992; 263: 92-8.
20. Dandona P, Karne R, Ghanim H, Hamouda W, Aljada A, Magsino CH. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. Circulation 2000; 101: 122-4.
21. Dandona P, Ghanim H, Brooks DP. Antioxidant activity of carvedilol in cardiovascular disease. J. Hypertens. 2007; 25: 731-41.